Search

everythinglearnresearchcommunity

for

Search:↓

European dermatologic treatments focus on lifestyle and psychosocial factors, use diverse methods like baths and climate therapy, and emphasize the importance of diet and supplements for skin health.

Skin changes are key for early diagnosis and treatment of rheumatic diseases.

COVID-19 can cause skin symptoms that might help spot the virus early, and treatments for it can also affect the skin.

Some COVID-19 pneumonia patients in Veracruz, Mexico, had skin issues, with reversible hair loss linked to disease severity.

Women of child-bearing age with androgenic alopecia lose hair density, especially in certain areas, and their hair becomes thinner. They also lose more than twice as much hair as healthy women.

Chemotherapy often causes hair loss, mouth sores, and dry skin.

COVID-19 can cause various skin issues in children, mostly not severe, with chilblain-like lesions being common, especially in adolescents.

Skin problems in patients with polycystic ovarian disease are linked to body weight, blood sugar, and hormone levels.

Losartan may help treat Postural Orthostatic Tachycardia Syndrome (POTS) symptoms.

Melatonin, the sleep hormone, can help treat skin conditions like dermatitis, hyperpigmentation, and scalp disorders, and may also aid in skin aging prevention and regeneration. However, it's not recommended for asthma due to its pro-inflammatory effect.

YH0618 helped reduce skin and nail problems and fatigue in chemotherapy patients.

Skin problems are common in the elderly, with itching and wrinkling being the most frequent issues.

Skin problems are common in kidney disease, with dry skin and itching in patients not on dialysis or on hemodialysis, and infections most common in transplant recipients.

Common skin conditions can greatly affect a person's mental health and social life.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Certain types of rashes in COVID-19 patients may indicate more severe illness and higher risk of death.

Some recovered COVID-19 patients experience skin, hair, and nail issues, suggesting they need follow-up care.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.

Skin and hair changes in horses can indicate serious diseases, and recognizing these signs is important for treatment and management.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

During the COVID-19 pandemic, a clinic in Turkey saw fewer patients but more cases of certain skin conditions, possibly linked to the virus and stress.

Skin diseases, especially psoriasis, greatly affect people's quality of life, similar to chronic diseases.

Using anabolic androgenic steroids can cause serious, lasting health problems in many parts of the body.

The document concludes that syphilis has varied symptoms that are often missed, making clinical awareness crucial for diagnosis.

Skin problems are common in people with diabetes and controlling blood sugar can reduce these issues.

Sleep problems and skin issues affect each other; poor sleep can worsen skin conditions, and some skin treatments can improve or harm sleep quality.

The document concludes that some dermatology books are useful for their photos or specific topics, while others have limitations like poor quality images or content.